1. Home
  2. FWRD vs RGNX Comparison

FWRD vs RGNX Comparison

Compare FWRD & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

HOLD

Current Price

$21.76

Market Cap

871.2M

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.57

Market Cap

761.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWRD
RGNX
Founded
1981
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
871.2M
761.9M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
FWRD
RGNX
Price
$21.76
$8.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$38.50
$29.13
AVG Volume (30 Days)
602.0K
865.1K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
$1,269,573,000.00
$10,393,000.00
Revenue This Year
$6.77
$116.76
Revenue Next Year
$6.83
$49.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$9.79
$5.04
52 Week High
$32.47
$16.19

Technical Indicators

Market Signals
Indicator
FWRD
RGNX
Relative Strength Index (RSI) 29.02 39.40
Support Level $16.46 $7.80
Resistance Level $23.20 $9.28
Average True Range (ATR) 1.44 0.63
MACD -0.50 0.22
Stochastic Oscillator 7.39 46.57

Price Performance

Historical Comparison
FWRD
RGNX

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: